Cover |
Nov. 26, 2025 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | This Current Report on Form 8-K/A (this “Amendment”) amends the Current Report on Form 8-K of Actinium Pharmaceuticals, Inc. (the “Company”) filed with the U.S. Securities and Exchange Commission on November 26, 2025 (the “Original Form 8-K”). The Original Form 8-K reported the final voting results of the Company’s Annual General Meeting of Shareholders held on November 26, 2025 (the “Annual Meeting”). The sole purpose of this Amendment is to disclose the Company’s decision regarding how frequently it will conduct future shareholder advisory votes to approve the compensation of the Company’s named executive officers (“Say-on-Pay Vote(s)”) in accordance with Item 5.07(d) of Form 8-K. No other changes have been made to the Original Form 8-K. |
| Document Period End Date | Nov. 26, 2025 |
| Entity File Number | 001-36374 |
| Entity Registrant Name | Actinium Pharmaceuticals, Inc. |
| Entity Central Index Key | 0001388320 |
| Entity Tax Identification Number | 74-2963609 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 100 Park Ave. |
| Entity Address, Address Line Two | 23rd Floor |
| Entity Address, City or Town | New York |
| Entity Address, State or Province | NY |
| Entity Address, Postal Zip Code | 10017 |
| City Area Code | 646 |
| Local Phone Number | 677-3870 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.001 per share |
| Trading Symbol | ATNM |
| Security Exchange Name | NYSEAMER |
| Entity Emerging Growth Company | false |
| Entity Information, Former Legal or Registered Name | Not applicable |